Pharmacovigilance In Juvenile Idiopathic Arthritis Patients Treated With Biologic Agents And/Or Methotrexate. A Pediatric Rheumatology International Trials Organisation (PRINTO)/Pediatric Rheumatology European Society (PRES) Registry (Pharmachild JIA registry)

First published 25/05/2011

Last updated 15/05/2024

EU PAS number:

EUPAS1974

Study

Ongoing

Documents

Study protocol

Initial protocol

Pharmachild_protocol_v3

English (242.64 KB - PDF)View document

Updated protocol

Pharmachild_protocol_v4

First published: 22/02/2024

English (243.63 KB - PDF)View document

Study results

Study report

Other information

ENCePP Seal

This study has been awarded the ENCePP seal

ENCePP Seal documents

Conflicts of interest of investigators

EUPAS1974-1994

English (55.05 KB - PDF)View document

Composition of steering group and observers

Steering and Observer Comm

English (153.4 KB - PDF)View document

Signed code of conduct

2011-0005-CoCdecl 10.05.2011

English (48.31 KB - PDF)View document

Signed code of conduct checklist

2011-0005-CoCcklist 10.05.2011

English (888.29 KB - PDF)View document

Signed checklist for study protocols

2011-0005-Protocol Chlist 10.05.2011

English (182 KB - PDF)View document

Secondary tabs